Get An Even Better Deal On ACHN Than Director Liotta Did
June 20, 2012 at 11:13 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on June 12, Achillion Pharmaceuticals Inc.'s Director, Dennis Liotta, invested $123,890.00 into 20,000 shares of ACHN, for a cost per share of $6.19.
